ACE2 and COVID-19: The prominent role of ACE2 in many of the physiological systems altered in COVID-19, including the multifocal tissue damage in the microcirculatory environment of many organs, supports the argument that SARS-CoV-2 activity provokes a transient molecular disease resulting in part from reduced ACE2 activity [23,24].